TP53 and cancer: However, the direct interaction of LSD1 with p53 inhibits p53-mediated transcriptional activation and apoptosis, resulting in altering the chromatin structure and inhibiting the development of the cancer marker alpha-fetoprotein (AFP) (Wen and Wang, 2022).